Ongoing Pharmacological Management of Chronic Pain in Pregnancy (Q38827847)

6 September 2017

1 reference

title

Ongoing Pharmacological Management of Chronic Pain in Pregnancy (English)

1 reference

6 September 2017

0 references

0 references

Bengt Källén

1 reference

6 September 2017

Margareta Reis

series ordinal

1 reference

6 September 2017

publication date

6 May 2016

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

915-924

1 reference

Maternal treatment with opioid analgesics and risk for birth defects

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

The Danish National Birth Cohort - its background, structure and aim

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Conditions for bias from differential left truncation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

First trimester maternal medication use in relation to gastroschisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Maternal medication use and risks of gastroschisis and small intestinal atresia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Epidemiologic analysis of maternal factors and amniotic band defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Maternal medications and environmental exposures as risk factors for gastroschisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Contribution of Demographic and Environmental Factors to the Etiology of Gastroschisis: A Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Fetal Growth and Adverse Birth Outcomes in Women Receiving Prescriptions for Acetaminophen During Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Acetaminophen use during pregnancy: effects on risk for congenital abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Nonsteroidal anti-inflammatory drugs in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Triptan safety during pregnancy: a Norwegian population registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

A population-based case-control teratologic study of oral dipyrone treatment during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Maternal drug use in early pregnancy and infant cardiovascular defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Periconceptional use of opioids and the risk of neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Effects of codeine on pregnancy outcome: results from a large population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Use of tramadol in early pregnancy and congenital malformation risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Delivery outcome after maternal use of drugs for migraine: a register study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

The safety of sumatriptan and naratriptan in pregnancy: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

The use of central nervous system active drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

NSAIDs: Maternal and Fetal Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Erratum: neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Consequences of prenatal substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Use of paracetamol during pregnancy and child neurological development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Association Between Prenatal Acetaminophen Exposure and Future Risk of Attention Deficit/Hyperactivity Disorder in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms during adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Paracetamol use in pregnancy and wheezing in early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

Maternal drug use during pregnancy and asthma risk among children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0582-3

A possible dose-dependent teratogenic effect of ergotamine

21 January 2018

1 reference

12 December 2020

Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study

1 reference

12 December 2020

Prenatal exposure to salicylates and gastroschisis: A case-control study

1 reference

12 December 2020

Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements

1 reference

12 December 2020

Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes

1 reference

12 December 2020

Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure

1 reference

12 December 2020

Association between prenatal exposure to analgesics and risk of schizophrenia

1 reference

12 December 2020

The Danish National Birth Cohort--its background, structure and aim.

1 reference

12 December 2020

Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study

1 reference

12 December 2020

Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis

1 reference

12 December 2020

10.1007/S40265-016-0582-3

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1007368794

0 references

1 reference